Racial Differences in Patient Portal Activation and Research Enrollment Among Patients With Prostate Cancer.
Journal
JCO clinical cancer informatics
ISSN: 2473-4276
Titre abrégé: JCO Clin Cancer Inform
Pays: United States
ID NLM: 101708809
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
entrez:
30
7
2021
pubmed:
31
7
2021
medline:
3
11
2021
Statut:
ppublish
Résumé
The purpose of this study was to examine racial differences in patient portal activation and research participation among patients with prostate cancer. Participants were African American and White patients with prostate cancer who were treated with radical prostatectomy (n = 218). Patient portal activation was determined using electronic health records, and research participation was measured based on completion of a social determinants survey. Thirty-one percent of patients completed the social determinants survey and enrolled in the study and 66% activated a patient portal. The likelihood of enrolling in the study was reduced with greater levels of social deprivation (odds ratio [OR], 0.70; 95% CI, 0.50 to 0.98; Although the majority of patients with prostate cancer activated their patient portal, rates of patient portal activation were lower among African American patients and those who lived in areas with greater social deprivation. Greater efforts are needed to promote patient portal activation among African American patients with prostate cancer and address access to health information technology among those who live in socially disadvantaged geographic areas.
Identifiants
pubmed: 34328797
doi: 10.1200/CCI.20.00131
pmc: PMC8812608
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
768-774Subventions
Organisme : NCI NIH HHS
ID : K00 CA253576
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54 MD010706
Pays : United States
Organisme : NCI NIH HHS
ID : UG1 CA189848
Pays : United States
Références
Popul Health Manag. 2021 Feb;24(1):52-58
pubmed: 32119804
Perm J. 2018 Oct 05;22:18-089
pubmed: 30296397
JMIR Med Inform. 2017 Nov 14;5(4):e47
pubmed: 29138129
JAMA Netw Open. 2020 Mar 2;3(3):e201839
pubmed: 32232449
Ann Intern Med. 2018 Apr 17;168(8):577-578
pubmed: 29677265
BMC Cancer. 2015 Mar 27;15:186
pubmed: 25885634
JAMIA Open. 2018 Oct;1(2):202-209
pubmed: 30474076
Am J Prev Med. 2017 Feb;52(2):199-206
pubmed: 27659121
Ann Fam Med. 2018 Sep;16(5):399-407
pubmed: 30201636
J Med Internet Res. 2019 Apr 11;21(4):e12779
pubmed: 30973347
J Natl Cancer Inst. 2019 Mar 1;111(3):245-255
pubmed: 30856272
Prostate Cancer Prostatic Dis. 2015 Jun;18(2):149-54
pubmed: 25667110
Am J Public Health. 2008 Sep;98(9):1608-15
pubmed: 18633099
Semin Oncol Nurs. 2018 May;34(2):177-183
pubmed: 29625803
Acad Pathol. 2018 Oct 04;5:2374289518797573
pubmed: 30302394
AIMS Public Health. 2019 Jul 3;6(3):209-224
pubmed: 31637271
Diabetes Technol Ther. 2015 Feb;17(2):80-7
pubmed: 25361382
Am J Public Health. 2010 Apr 1;100 Suppl 1:S19-24
pubmed: 20147662
Fed Regist. 2010 Jul 28;75(144):44313-588
pubmed: 20677415
J Am Board Fam Med. 2016 Sep-Oct;29(5):592-603
pubmed: 27613792
Health Serv Res. 2013 Apr;48(2 Pt 1):539-59
pubmed: 22816561
Contemp Clin Trials Commun. 2018 Aug 07;11:156-164
pubmed: 30112460
J Am Med Inform Assoc. 2019 Dec 1;26(12):1637-1644
pubmed: 31532482
Support Care Cancer. 2019 Feb;27(2):531-538
pubmed: 30003341
Trials. 2015 Jun 05;16:258
pubmed: 26044763
BMC Endocr Disord. 2014 Oct 09;14:82
pubmed: 25298071
BMC Public Health. 2018 Apr 24;18(1):550
pubmed: 29699539
Fed Regist. 2012 Sep 4;77(171):53967-4162
pubmed: 22946138
J Am Med Inform Assoc. 2019 Aug 1;26(8-9):855-870
pubmed: 30958532
Implement Sci. 2020 Jul 29;15(1):60
pubmed: 32727493
Comput Inform Nurs. 2018 Jan;36(1):18-26
pubmed: 29049084
J Clin Oncol. 2015 Oct 1;33(28):3177-85
pubmed: 26304878